Embody vs Hims: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

Visit Embody - $149/mo→or find your match

Hims beats Embody overall, scoring 7.9/10 vs 7.3/10. Embody is more affordable at $149/mo vs $199/mo. Choose Embody for people who want the oral tirzepatide gum, or who'll choose t. Choose Hims for men who want a well-known publicly-traded brand and fda-appr.

A side-by-side look at Embody and Hims to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Embody

#37 of 52

7.3/10

Online weight-loss program that ships compounded GLP-1 medication to your door. Run by Modern Metabolic Medicine, Inc. and prescribed through CareGLP Affiliated P.C.s, their network of licensed doctors. Two pricing plans run side by side: a promo plan starting at $99/mo for semaglutide (or $149/mo for tirzepatide) that jumps after month 1, and 'Embody Flat' at $299/mo that doesn't go up. Their standout: oral tirzepatide gum, for people who don't want to inject.

Visit Embody

Higher Rated

Hims

#9 of 52

7.9/10

The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy (injection and pill) and Ozempic through a direct Novo Nordisk partnership, alongside their existing compounded semaglutide program. Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026), significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28%, the highest 1-star rate in our table, clustered around subscription/billing complaints.

Visit Hims

Feature	Embody	Hims
Our Score	7.3/10	7.9/10
Starting Price	$149/mo	$199/mo
Medication Type	Compounded	Both
Insurance Accepted	No	No
Best For	People who want the oral tirzepatide gum, or who'll choose the $299/mo 'Embody Flat' plan at signup for one predictable price	Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors
Ranking	#37	#9
Get started	Visit Embody	Visit Hims

Pros & Cons Compared

Embody

Pros

+Oral tirzepatide gum is rare. Real option for needle-phobic users. (How well it absorbs vs the FDA-approved injection isn't published.)
+Cheap first month, $99 for semaglutide or $149 for tirzepatide. Among the lowest entry prices in the category.
+'Embody Flat' plan is $299/mo flat with no surprise increases, predictable if you pick it from the start.
+100% money-back guarantee in writing: if you follow the program and don't see results in 6 months, they say they'll make it right.
+Replies to every negative Trustpilot review, usually within 24 hours.

Cons

−Two plans run side by side and the switchover isn't always clear at signup: the $149 promo month steps up to $299–$399 from month 2 (Embody confirms both plans in its review replies). Pick 'Embody Flat' at signup if you want one predictable number.
−Trustpilot rating is a polarized 3.3 / 5 across 46 reviews: 41% five-star, 24% one-star. Price is the top complaint theme, most of it tied to the promo-to-flat switchover above.
−Embody doesn't name which pharmacy makes the medication, just 'multiple USA certified pharmacies.' This is the norm in the category, most major brands (Embody, Henry, Hims, Yucca, Eden) don't publicly name their pharmacy partners; ask support directly if provenance matters to you.
−No HIPAA disclosure on their site (HIPAA is the federal law protecting your medical info, most telehealth providers publish a statement confirming they follow it).
−Compounded medications only, no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
−If you stop treatment and come back, Embody's doctors will likely restart you at the lowest dose (2.5mg). It's their safety policy; raise your dose history at signup, the prescriber makes the final call.

Hims

Pros

+Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
+2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
+$199/mo all-inclusive for compounded semaglutide, including consultations and shipping.
+Polished app and web experience, among the best user interfaces in men's telehealth.
+8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.

Cons

−Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
−28% of Trustpilot reviews are 1-star, the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
−Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
−'Hims Oral Kit' is NOT a GLP-1, it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Easy to confuse with their compounded semaglutide. Read the product page carefully before signing up.
−Brand Wegovy at $599/mo is not competitive with LillyDirect/NovoCare cash prices or with Hers ($149/mo for the same product via the same Novo partnership).
−Generic high-volume support, large patient base means less personalized attention than smaller competitors.

Our Verdict

Hims edges out Embody with a score of 7.9/10 vs 7.3/10. If budget is your priority, Embody starts at $149/mo compared to Hims's $199/mo. Hims offers both brand-name and compounded medications, giving you more flexibility. Choose Embody if you want: people who want the oral tirzepatide gum, or who'll choose the $299/mo 'embody flat' plan at signup for one predictable price. Choose Hims if you want: men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Embody nor Hims feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review